NFKB1 and diabetes mellitus: It seems that MAPK/NF-κB activation is involved in the pathogenesis of high glucose-induced cell dysfunction and apoptosis, suggesting that agents which can block MAPK/NF-κB signaling might be effective in treating diabetes complications [10].